The global market for Necrotizing Autoimmune Myositis is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Necrotizing Autoimmune Myositis market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Necrotizing Autoimmune Myositis market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Necrotizing Autoimmune Myositis market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Necrotizing Autoimmune Myositis market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Necrotizing Autoimmune Myositis players cover GlaxoSmithKline plc, Dr. Reddy's Laboratories, Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.), Hetero Drugs Limited and AbbVie Inc., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Necrotizing Autoimmune Myositis market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Necrotizing Autoimmune Myositis market, with both quantitative and qualitative data, to help readers understand how the Necrotizing Autoimmune Myositis market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Necrotizing Autoimmune Myositis market and forecasts the market size by Type (Steroid Drugs, Immunosuppressant and Others), by Application (Hospital, Pharmacy and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Steroid Drugs
Immunosuppressant
Others
Segmentation by application
Hospital
Pharmacy
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
GlaxoSmithKline plc
Dr. Reddy's Laboratories
Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.)
Hetero Drugs Limited
AbbVie Inc.
Teva Pharmaceutical Industries
Novartis AG
Chapter Introduction
Chapter 1: Scope of Necrotizing Autoimmune Myositis, Research Methodology, etc.
Chapter 2: Executive Summary, global Necrotizing Autoimmune Myositis market size and CAGR, Necrotizing Autoimmune Myositis market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Necrotizing Autoimmune Myositis revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Necrotizing Autoimmune Myositis revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Necrotizing Autoimmune Myositis market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including GlaxoSmithKline plc, Dr. Reddy's Laboratories, Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.), Hetero Drugs Limited, AbbVie Inc., Teva Pharmaceutical Industries and Novartis AG, etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Necrotizing Autoimmune Myositis Market Size 2017-2028
2.1.2 Necrotizing Autoimmune Myositis Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Necrotizing Autoimmune Myositis Segment by Type
2.2.1 Steroid Drugs
2.2.2 Immunosuppressant
2.2.3 Others
2.3 Necrotizing Autoimmune Myositis Market Size by Type
2.3.1 Necrotizing Autoimmune Myositis Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Necrotizing Autoimmune Myositis Market Size Market Share by Type (2017-2022)
2.4 Necrotizing Autoimmune Myositis Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.4.3 Others
2.5 Necrotizing Autoimmune Myositis Market Size by Application
2.5.1 Necrotizing Autoimmune Myositis Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Necrotizing Autoimmune Myositis Market Size Market Share by Application (2017-2022)
3 Necrotizing Autoimmune Myositis Market Size by Player
3.1 Necrotizing Autoimmune Myositis Market Size Market Share by Players
3.1.1 Global Necrotizing Autoimmune Myositis Revenue by Players (2020-2022)
3.1.2 Global Necrotizing Autoimmune Myositis Revenue Market Share by Players (2020-2022)
3.2 Global Necrotizing Autoimmune Myositis Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Necrotizing Autoimmune Myositis by Regions
4.1 Necrotizing Autoimmune Myositis Market Size by Regions (2017-2022)
4.2 Americas Necrotizing Autoimmune Myositis Market Size Growth (2017-2022)
4.3 APAC Necrotizing Autoimmune Myositis Market Size Growth (2017-2022)
4.4 Europe Necrotizing Autoimmune Myositis Market Size Growth (2017-2022)
4.5 Middle East & Africa Necrotizing Autoimmune Myositis Market Size Growth (2017-2022)
5 Americas
5.1 Americas Necrotizing Autoimmune Myositis Market Size by Country (2017-2022)
5.2 Americas Necrotizing Autoimmune Myositis Market Size by Type (2017-2022)
5.3 Americas Necrotizing Autoimmune Myositis Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Necrotizing Autoimmune Myositis Market Size by Region (2017-2022)
6.2 APAC Necrotizing Autoimmune Myositis Market Size by Type (2017-2022)
6.3 APAC Necrotizing Autoimmune Myositis Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Necrotizing Autoimmune Myositis by Country (2017-2022)
7.2 Europe Necrotizing Autoimmune Myositis Market Size by Type (2017-2022)
7.3 Europe Necrotizing Autoimmune Myositis Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Necrotizing Autoimmune Myositis by Region (2017-2022)
8.2 Middle East & Africa Necrotizing Autoimmune Myositis Market Size by Type (2017-2022)
8.3 Middle East & Africa Necrotizing Autoimmune Myositis Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Necrotizing Autoimmune Myositis Market Forecast
10.1 Global Necrotizing Autoimmune Myositis Forecast by Regions (2023-2028)
10.1.1 Global Necrotizing Autoimmune Myositis Forecast by Regions (2023-2028)
10.1.2 Americas Necrotizing Autoimmune Myositis Forecast
10.1.3 APAC Necrotizing Autoimmune Myositis Forecast
10.1.4 Europe Necrotizing Autoimmune Myositis Forecast
10.1.5 Middle East & Africa Necrotizing Autoimmune Myositis Forecast
10.2 Americas Necrotizing Autoimmune Myositis Forecast by Country (2023-2028)
10.2.1 United States Necrotizing Autoimmune Myositis Market Forecast
10.2.2 Canada Necrotizing Autoimmune Myositis Market Forecast
10.2.3 Mexico Necrotizing Autoimmune Myositis Market Forecast
10.2.4 Brazil Necrotizing Autoimmune Myositis Market Forecast
10.3 APAC Necrotizing Autoimmune Myositis Forecast by Region (2023-2028)
10.3.1 China Necrotizing Autoimmune Myositis Market Forecast
10.3.2 Japan Necrotizing Autoimmune Myositis Market Forecast
10.3.3 Korea Necrotizing Autoimmune Myositis Market Forecast
10.3.4 Southeast Asia Necrotizing Autoimmune Myositis Market Forecast
10.3.5 India Necrotizing Autoimmune Myositis Market Forecast
10.3.6 Australia Necrotizing Autoimmune Myositis Market Forecast
10.4 Europe Necrotizing Autoimmune Myositis Forecast by Country (2023-2028)
10.4.1 Germany Necrotizing Autoimmune Myositis Market Forecast
10.4.2 France Necrotizing Autoimmune Myositis Market Forecast
10.4.3 UK Necrotizing Autoimmune Myositis Market Forecast
10.4.4 Italy Necrotizing Autoimmune Myositis Market Forecast
10.4.5 Russia Necrotizing Autoimmune Myositis Market Forecast
10.5 Middle East & Africa Necrotizing Autoimmune Myositis Forecast by Region (2023-2028)
10.5.1 Egypt Necrotizing Autoimmune Myositis Market Forecast
10.5.2 South Africa Necrotizing Autoimmune Myositis Market Forecast
10.5.3 Israel Necrotizing Autoimmune Myositis Market Forecast
10.5.4 Turkey Necrotizing Autoimmune Myositis Market Forecast
10.5.5 GCC Countries Necrotizing Autoimmune Myositis Market Forecast
10.6 Global Necrotizing Autoimmune Myositis Forecast by Type (2023-2028)
10.7 Global Necrotizing Autoimmune Myositis Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 GlaxoSmithKline plc
11.1.1 GlaxoSmithKline plc Company Information
11.1.2 GlaxoSmithKline plc Necrotizing Autoimmune Myositis Product Offered
11.1.3 GlaxoSmithKline plc Necrotizing Autoimmune Myositis Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 GlaxoSmithKline plc Main Business Overview
11.1.5 GlaxoSmithKline plc Latest Developments
11.2 Dr. Reddy's Laboratories
11.2.1 Dr. Reddy's Laboratories Company Information
11.2.2 Dr. Reddy's Laboratories Necrotizing Autoimmune Myositis Product Offered
11.2.3 Dr. Reddy's Laboratories Necrotizing Autoimmune Myositis Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Dr. Reddy's Laboratories Main Business Overview
11.2.5 Dr. Reddy's Laboratories Latest Developments
11.3 Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.)
11.3.1 Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.) Company Information
11.3.2 Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.) Necrotizing Autoimmune Myositis Product Offered
11.3.3 Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.) Necrotizing Autoimmune Myositis Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.) Main Business Overview
11.3.5 Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.) Latest Developments
11.4 Hetero Drugs Limited
11.4.1 Hetero Drugs Limited Company Information
11.4.2 Hetero Drugs Limited Necrotizing Autoimmune Myositis Product Offered
11.4.3 Hetero Drugs Limited Necrotizing Autoimmune Myositis Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Hetero Drugs Limited Main Business Overview
11.4.5 Hetero Drugs Limited Latest Developments
11.5 AbbVie Inc.
11.5.1 AbbVie Inc. Company Information
11.5.2 AbbVie Inc. Necrotizing Autoimmune Myositis Product Offered
11.5.3 AbbVie Inc. Necrotizing Autoimmune Myositis Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 AbbVie Inc. Main Business Overview
11.5.5 AbbVie Inc. Latest Developments
11.6 Teva Pharmaceutical Industries
11.6.1 Teva Pharmaceutical Industries Company Information
11.6.2 Teva Pharmaceutical Industries Necrotizing Autoimmune Myositis Product Offered
11.6.3 Teva Pharmaceutical Industries Necrotizing Autoimmune Myositis Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Teva Pharmaceutical Industries Main Business Overview
11.6.5 Teva Pharmaceutical Industries Latest Developments
11.7 Novartis AG
11.7.1 Novartis AG Company Information
11.7.2 Novartis AG Necrotizing Autoimmune Myositis Product Offered
11.7.3 Novartis AG Necrotizing Autoimmune Myositis Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Novartis AG Main Business Overview
11.7.5 Novartis AG Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Necrotizing Autoimmune Myositis Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Steroid Drugs
Table 3. Major Players of Immunosuppressant
Table 4. Major Players of Others
Table 5. Necrotizing Autoimmune Myositis Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Necrotizing Autoimmune Myositis Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Necrotizing Autoimmune Myositis Market Size Market Share by Type (2017-2022)
Table 8. Necrotizing Autoimmune Myositis Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Necrotizing Autoimmune Myositis Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Necrotizing Autoimmune Myositis Market Size Market Share by Application (2017-2022)
Table 11. Global Necrotizing Autoimmune Myositis Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Necrotizing Autoimmune Myositis Revenue Market Share by Player (2020-2022)
Table 13. Necrotizing Autoimmune Myositis Key Players Head office and Products Offered
Table 14. Necrotizing Autoimmune Myositis Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Necrotizing Autoimmune Myositis Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Necrotizing Autoimmune Myositis Market Size Market Share by Regions (2017-2022)
Table 19. Americas Necrotizing Autoimmune Myositis Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Necrotizing Autoimmune Myositis Market Size Market Share by Country (2017-2022)
Table 21. Americas Necrotizing Autoimmune Myositis Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Necrotizing Autoimmune Myositis Market Size Market Share by Type (2017-2022)
Table 23. Americas Necrotizing Autoimmune Myositis Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Necrotizing Autoimmune Myositis Market Size Market Share by Application (2017-2022)
Table 25. APAC Necrotizing Autoimmune Myositis Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Necrotizing Autoimmune Myositis Market Size Market Share by Region (2017-2022)
Table 27. APAC Necrotizing Autoimmune Myositis Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Necrotizing Autoimmune Myositis Market Size Market Share by Type (2017-2022)
Table 29. APAC Necrotizing Autoimmune Myositis Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Necrotizing Autoimmune Myositis Market Size Market Share by Application (2017-2022)
Table 31. Europe Necrotizing Autoimmune Myositis Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Necrotizing Autoimmune Myositis Market Size Market Share by Country (2017-2022)
Table 33. Europe Necrotizing Autoimmune Myositis Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Necrotizing Autoimmune Myositis Market Size Market Share by Type (2017-2022)
Table 35. Europe Necrotizing Autoimmune Myositis Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Necrotizing Autoimmune Myositis Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Necrotizing Autoimmune Myositis Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Necrotizing Autoimmune Myositis Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Necrotizing Autoimmune Myositis Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Necrotizing Autoimmune Myositis Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Necrotizing Autoimmune Myositis Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Necrotizing Autoimmune Myositis Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Necrotizing Autoimmune Myositis
Table 44. Key Market Challenges & Risks of Necrotizing Autoimmune Myositis
Table 45. Key Industry Trends of Necrotizing Autoimmune Myositis
Table 46. Global Necrotizing Autoimmune Myositis Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Necrotizing Autoimmune Myositis Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Necrotizing Autoimmune Myositis Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Necrotizing Autoimmune Myositis Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Necrotizing Autoimmune Myositis Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Necrotizing Autoimmune Myositis Market Size Market Share Forecast by Application (2023-2028)
Table 52. GlaxoSmithKline plc Details, Company Type, Necrotizing Autoimmune Myositis Area Served and Its Competitors
Table 53. GlaxoSmithKline plc Necrotizing Autoimmune Myositis Product Offered
Table 54. GlaxoSmithKline plc Necrotizing Autoimmune Myositis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. GlaxoSmithKline plc Main Business
Table 56. GlaxoSmithKline plc Latest Developments
Table 57. Dr. Reddy's Laboratories Details, Company Type, Necrotizing Autoimmune Myositis Area Served and Its Competitors
Table 58. Dr. Reddy's Laboratories Necrotizing Autoimmune Myositis Product Offered
Table 59. Dr. Reddy's Laboratories Main Business
Table 60. Dr. Reddy's Laboratories Necrotizing Autoimmune Myositis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Dr. Reddy's Laboratories Latest Developments
Table 62. Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.) Details, Company Type, Necrotizing Autoimmune Myositis Area Served and Its Competitors
Table 63. Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.) Necrotizing Autoimmune Myositis Product Offered
Table 64. Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.) Main Business
Table 65. Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.) Necrotizing Autoimmune Myositis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.) Latest Developments
Table 67. Hetero Drugs Limited Details, Company Type, Necrotizing Autoimmune Myositis Area Served and Its Competitors
Table 68. Hetero Drugs Limited Necrotizing Autoimmune Myositis Product Offered
Table 69. Hetero Drugs Limited Main Business
Table 70. Hetero Drugs Limited Necrotizing Autoimmune Myositis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Hetero Drugs Limited Latest Developments
Table 72. AbbVie Inc. Details, Company Type, Necrotizing Autoimmune Myositis Area Served and Its Competitors
Table 73. AbbVie Inc. Necrotizing Autoimmune Myositis Product Offered
Table 74. AbbVie Inc. Main Business
Table 75. AbbVie Inc. Necrotizing Autoimmune Myositis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. AbbVie Inc. Latest Developments
Table 77. Teva Pharmaceutical Industries Details, Company Type, Necrotizing Autoimmune Myositis Area Served and Its Competitors
Table 78. Teva Pharmaceutical Industries Necrotizing Autoimmune Myositis Product Offered
Table 79. Teva Pharmaceutical Industries Main Business
Table 80. Teva Pharmaceutical Industries Necrotizing Autoimmune Myositis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Teva Pharmaceutical Industries Latest Developments
Table 82. Novartis AG Details, Company Type, Necrotizing Autoimmune Myositis Area Served and Its Competitors
Table 83. Novartis AG Necrotizing Autoimmune Myositis Product Offered
Table 84. Novartis AG Main Business
Table 85. Novartis AG Necrotizing Autoimmune Myositis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Novartis AG Latest Developments
List of Figures
List of Figures
Figure 1. Necrotizing Autoimmune Myositis Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Necrotizing Autoimmune Myositis Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Necrotizing Autoimmune Myositis Market Size Market Share by Type in 2021
Figure 7. Necrotizing Autoimmune Myositis in Hospital
Figure 8. Global Necrotizing Autoimmune Myositis Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Necrotizing Autoimmune Myositis in Pharmacy
Figure 10. Global Necrotizing Autoimmune Myositis Market: Pharmacy (2017-2022) & ($ Millions)
Figure 11. Necrotizing Autoimmune Myositis in Others
Figure 12. Global Necrotizing Autoimmune Myositis Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Necrotizing Autoimmune Myositis Market Size Market Share by Application in 2021
Figure 14. Global Necrotizing Autoimmune Myositis Revenue Market Share by Player in 2021
Figure 15. Global Necrotizing Autoimmune Myositis Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Necrotizing Autoimmune Myositis Market Size 2017-2022 ($ Millions)
Figure 17. APAC Necrotizing Autoimmune Myositis Market Size 2017-2022 ($ Millions)
Figure 18. Europe Necrotizing Autoimmune Myositis Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Necrotizing Autoimmune Myositis Market Size 2017-2022 ($ Millions)
Figure 20. Americas Necrotizing Autoimmune Myositis Value Market Share by Country in 2021
Figure 21. Americas Necrotizing Autoimmune Myositis Consumption Market Share by Type in 2021
Figure 22. Americas Necrotizing Autoimmune Myositis Market Size Market Share by Application in 2021
Figure 23. United States Necrotizing Autoimmune Myositis Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Necrotizing Autoimmune Myositis Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Necrotizing Autoimmune Myositis Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Necrotizing Autoimmune Myositis Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Necrotizing Autoimmune Myositis Market Size Market Share by Region in 2021
Figure 28. APAC Necrotizing Autoimmune Myositis Market Size Market Share by Application in 2021
Figure 29. China Necrotizing Autoimmune Myositis Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Necrotizing Autoimmune Myositis Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Necrotizing Autoimmune Myositis Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Necrotizing Autoimmune Myositis Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Necrotizing Autoimmune Myositis Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Necrotizing Autoimmune Myositis Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Necrotizing Autoimmune Myositis Market Size Market Share by Country in 2021
Figure 36. Europe Necrotizing Autoimmune Myositis Market Size Market Share by Type in 2021
Figure 37. Europe Necrotizing Autoimmune Myositis Market Size Market Share by Application in 2021
Figure 38. Germany Necrotizing Autoimmune Myositis Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Necrotizing Autoimmune Myositis Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Necrotizing Autoimmune Myositis Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Necrotizing Autoimmune Myositis Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Necrotizing Autoimmune Myositis Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Necrotizing Autoimmune Myositis Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Necrotizing Autoimmune Myositis Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Necrotizing Autoimmune Myositis Market Size Market Share by Application in 2021
Figure 46. Egypt Necrotizing Autoimmune Myositis Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Necrotizing Autoimmune Myositis Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Necrotizing Autoimmune Myositis Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Necrotizing Autoimmune Myositis Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Necrotizing Autoimmune Myositis Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Necrotizing Autoimmune Myositis Market Size 2023-2028 ($ Millions)
Figure 52. APAC Necrotizing Autoimmune Myositis Market Size 2023-2028 ($ Millions)
Figure 53. Europe Necrotizing Autoimmune Myositis Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Necrotizing Autoimmune Myositis Market Size 2023-2028 ($ Millions)
Figure 55. United States Necrotizing Autoimmune Myositis Market Size 2023-2028 ($ Millions)
Figure 56. Canada Necrotizing Autoimmune Myositis Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Necrotizing Autoimmune Myositis Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Necrotizing Autoimmune Myositis Market Size 2023-2028 ($ Millions)
Figure 59. China Necrotizing Autoimmune Myositis Market Size 2023-2028 ($ Millions)
Figure 60. Japan Necrotizing Autoimmune Myositis Market Size 2023-2028 ($ Millions)
Figure 61. Korea Necrotizing Autoimmune Myositis Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Necrotizing Autoimmune Myositis Market Size 2023-2028 ($ Millions)
Figure 63. India Necrotizing Autoimmune Myositis Market Size 2023-2028 ($ Millions)
Figure 64. Australia Necrotizing Autoimmune Myositis Market Size 2023-2028 ($ Millions)
Figure 65. Germany Necrotizing Autoimmune Myositis Market Size 2023-2028 ($ Millions)
Figure 66. France Necrotizing Autoimmune Myositis Market Size 2023-2028 ($ Millions)
Figure 67. UK Necrotizing Autoimmune Myositis Market Size 2023-2028 ($ Millions)
Figure 68. Italy Necrotizing Autoimmune Myositis Market Size 2023-2028 ($ Millions)
Figure 69. Russia Necrotizing Autoimmune Myositis Market Size 2023-2028 ($ Millions)
Figure 70. Spain Necrotizing Autoimmune Myositis Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Necrotizing Autoimmune Myositis Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Necrotizing Autoimmune Myositis Market Size 2023-2028 ($ Millions)
Figure 73. Israel Necrotizing Autoimmune Myositis Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Necrotizing Autoimmune Myositis Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Necrotizing Autoimmune Myositis Market Size 2023-2028 ($ Millions)